Home > Healthcare > Medical Devices > Therapeutic Devices > Leukapheresis Market

Leukapheresis Market Size

Report ID: GMI10924
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Leukapheresis Market Size

Leukapheresis market was valued at around USD 281.8 million in 2023 and is estimated to grow at 12.7% CAGR from 2024 to 2032. Leukapheresis is a specialized medical procedure designed to extract and collect white blood cells (leukocytes) from a patient's bloodstream. The process involves drawing blood from the patient, which is then filtered through a machine to isolate the white blood cells. Subsequently, the other blood components, such as red blood cells and platelets, are reintroduced into the patient's system.

To get key market trends

Download Free Sample

The escalating incidence of blood cancer stands out as a primary catalyst propelling the market's growth. For context, a report by the World Cancer Research Fund International (WCRF) highlighted that in 2022, there were 487,294 global diagnoses of blood cancer. This included 278,120 cases in males and 209,174 in females. Such statistics emphasize the surging demand for effective treatment modalities. Technologies like leukapheresis are pivotal in blood cancer management, adeptly removing abnormal white blood cells and enhancing patient care and treatment results.

Leukapheresis Market Report Attributes
Report Attribute	Details
Base Year:	2023
Leukapheresis Market Size in 2023:	USD 281.8 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	12.7%
2032 Value Projection:	USD 815.3 Million
Historical Data for:	2021 - 2023
No. of Pages:	195
Tables, Charts & Figures:	340
Segments covered:	Product, Application, End-use, and Region
Growth Drivers:	Rising cases of blood cancer and related disorders Innovations in leukapheresis devices and their procedures Surge in R&D focus on cell-based therapies and immunotherapy Supportive government initiatives and policies
Pitfalls & Challenges:	Expensive leukapheresis devices Shortage of trained professionals

Learn more about the key segments shaping this market

Download Free Sample

Additionally, the market is buoyed by innovations in leukapheresis devices and methodologies, heightened R&D focus on cell-based therapies and immunotherapy, and supportive government policies and initiatives.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Leukapheresis market size was USD 281.8 million in 2023 and is expected to register 12.7% CAGR from 2024-2032 owing to escalating incidence of blood cancer worldwide.

Leukapheresis industry from the disposables segment is expected to reach USD 502.6 million by 2032 due to providing reduced the risk of cross-contamination among patients.

The U.S. leukapheresis industry is expected to reach USD 280.5 million by 2032 due to development and adoption of cutting-edge leukapheresis technologies, including sophisticated apheresis equipment with advanced automation and real-time monitoring capabilities in the region.

Fresenius SE & Co. KGaA, Haemonetics Corporation, Macopharma, Medica SPA, Miltenyi Biotec, Mitra Industries Private Limited, Nikkiso Co. Ltd., Puriblood Medical Co. Ltd., SB-Kawasumi Laboratories, Inc., and Terumo BCT, Inc., are some of the major leukapheresis companies worldwide.